Atherosclerotic vascular disease in the autoimmune rheumatologic woman. Issue 2 (26th February 2018)

• Record Type: Journal Article
• Authors: Kurmann, Reto Daniel; Mankad, Rekha
• Other Names: Wenger Nanette K. guestEditor.; Gulati Martha guestEditor.
• Is Part Of: Clinical cardiology. Volume 41:Issue 2(2018)
• Page Start: 258
• Page End: 263
• Publication Date: 2018-02-26
• Subjects: Cardiology -- Periodicals; 616.12005
• DOI: 10.1002/clc.22916
• Languages: English
• ISSNs: 0160-9289

Abstract

Abstract : Autoimmune rheumatologic conditions have increased cardiovascular morbidity and mortality compared to the general population. Many of these diseases occur more commonly in women, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis, and Sjogren's. Most of the literature that has identified the link between autoimmune diseases and atherosclerotic cardiovascular disease (ASCVD) has been regarding patients with RA and SLE. The reason for the increased ASCVD is related to both traditional risk factors for atherosclerosis and nontraditional risk factors such as the burden of inflammation. Presently, our ability to adequately determinecardiovascular risk in the autoimmune patient is subpar, as scoring systems fail to take into account the role of inflammation. No present guidelines exist that take into account the increased burden of cardiovascular disease in this complex patient cohort.